Piscidic acid
CAS No. 469-65-8
Piscidic acid( —— )
Catalog No. M32380 CAS No. 469-65-8
Piscidic acid acts as an inhibitor of cholesterol permeation through Caco-2 cell monolayers and as an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 421 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePiscidic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiscidic acid acts as an inhibitor of cholesterol permeation through Caco-2 cell monolayers and as an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase.
-
DescriptionPiscidic acid acts as an inhibitor of cholesterol permeation through Caco-2 cell monolayers and as an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase. Piscidic acid have antioxidant and antimicrobial properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number469-65-8
-
Formula Weight256.21
-
Molecular FormulaC11H12O7
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arch Pharm Res . 2017 Nov;40(11):1278-1286.
molnova catalog
related products
-
α-Conotoxin SI
α-Conotoxin SI is a nicotinic acetylcholine receptor (nAChRs) blocker derived from sea snails and cone snails. α-Conotoxin SI can be used to study neurological disorders.
-
2-Hydroxy-1,7,8-trim...
OAT1/3-IN-2 (compound 8) is a dual inhibitor of OAT1 and OAT3. OAT1/3-IN-2 can reverse the toxicity of Cys-Hg on HEK-OAT1 cells (10 μM) and has a potential protective effect on the kidneys. OAT1/3-IN-2 can be used to study mercury-induced kidney damage.
-
Stiripentol
Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively.
Cart
sales@molnova.com